Diabetes Care:铁代谢的生化标志物与2型糖尿病的关系

2016-05-17 liyue译 MedSci原创

  有观察性研究发现铁蛋白和2型糖尿病有关,机体较高的铁储备可能参与了2型糖尿病的发展。然而铁蛋白不会被铁储备所影响,因此相对于其他标志物,铁蛋白并不能完全反映机体的铁代谢情况。研究人员通过观察铁蛋白、转铁蛋白饱和度(TSAT)、血清铁和转铁蛋白与2型糖尿病的发生,研究铁在2型糖尿病发病机制中的作用。  欧洲癌症与营养前瞻性调查(EPIC- InterAct)研究中对已明确诊断

有观察性研究发现铁蛋白和2型糖尿病有关,机体较高的铁储备可能参与了2型糖尿病的发展。然而铁蛋白不会被铁储备所影响,因此相对于其他标志物,铁蛋白并不能完全反映机体的铁代谢情况。研究人员通过观察铁蛋白、转铁蛋白饱和度(TSAT)、血清铁和转铁蛋白与2型糖尿病的发生,研究铁在2型糖尿病发病机制中的作用。此前也有类似的研究,如Diabetologia:铁缺乏导致HbA1c水平升高假象

欧洲癌症与营养前瞻性调查(EPIC- InterAct)研究中对已明确诊断为2型糖尿病并长期随访的12403例患者、以及有代表性的16154例亚群(在基线水平时被临床诊断为糖尿病)进行研究。研究人员观察了11052例2型糖尿病患者以及15182例亚群中2型糖尿病的发生与铁蛋白、转铁蛋白饱和度(TSAT)、血清铁和转铁蛋白的联系。

研究结果显示,校正了年龄、BMI、体力活动、吸烟状况、受教育程度、超敏c反应蛋白(hs-CRP)、丙氨酸氨基转移酶和γ-谷氨酰胺转移酶等因素后,较高水平的铁蛋白和转铁蛋白与2型糖尿病的风险增加有关(铁蛋白每增加100μg/L的危害比[95%置信区间]在男女中分别为1.07[1.01-1.12]和1.12[1.05-1.19];转铁蛋白每增加0.5g/L的危害比[95%置信区间]在男女中分别为1.11[1.00-1.14]和1.22[1.12-1.33])。在女性中,较高的TSAT (≥45% vs <45%) 与2型糖尿病风险降低有关(0.68[0.54-0.86]),但在男性中无统计学差异(0.90 [0.75–1.08])。血清铁与2型糖尿病无明显相关性。在较瘦的人群中,铁蛋白与2型糖尿病有更强的相关性。

综上所述,在研究者所构建的TSAT和转铁蛋白与2型糖尿病的模型提示了铁储备与2型糖尿病之间的潜在联系较为复杂,并不仅仅如前文中所提到的铁蛋白和2型糖尿病有关。

原始出处:
Podmore C,Meidtner K, Schulze MB,et al.Association of Multiple Biomarkers of Iron Metabolism and Type 2 Diabetes.Diabetes Care. 2016;39(4):572-581.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1840888, encodeId=0e921840888bf, content=<a href='/topic/show?id=18bf61953d3' target=_blank style='color:#2F92EE;'>#标志物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61953, encryptionId=18bf61953d3, topicName=标志物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ab940, createdName=hukaixun, createdTime=Tue Jun 28 02:48:00 CST 2016, time=2016-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1637329, encodeId=48ad163e32945, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Tue Dec 06 07:48:00 CST 2016, time=2016-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759665, encodeId=0adc1e5966582, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sat Oct 01 06:48:00 CST 2016, time=2016-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901373, encodeId=31cf19013e3e7, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Thu Mar 23 19:48:00 CST 2017, time=2017-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1507030, encodeId=27ea150e030c9, content=<a href='/topic/show?id=870c9653155' target=_blank style='color:#2F92EE;'>#铁代谢#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96531, encryptionId=870c9653155, topicName=铁代谢)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d84f9850762, createdName=syscxl, createdTime=Thu May 19 10:48:00 CST 2016, time=2016-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=86210, encodeId=340986210a8, content=近年来对一些金属离子的代谢对疾病的影响,也特别引人关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Tue May 17 21:26:00 CST 2016, time=2016-05-17, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1840888, encodeId=0e921840888bf, content=<a href='/topic/show?id=18bf61953d3' target=_blank style='color:#2F92EE;'>#标志物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61953, encryptionId=18bf61953d3, topicName=标志物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ab940, createdName=hukaixun, createdTime=Tue Jun 28 02:48:00 CST 2016, time=2016-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1637329, encodeId=48ad163e32945, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Tue Dec 06 07:48:00 CST 2016, time=2016-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759665, encodeId=0adc1e5966582, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sat Oct 01 06:48:00 CST 2016, time=2016-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901373, encodeId=31cf19013e3e7, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Thu Mar 23 19:48:00 CST 2017, time=2017-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1507030, encodeId=27ea150e030c9, content=<a href='/topic/show?id=870c9653155' target=_blank style='color:#2F92EE;'>#铁代谢#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96531, encryptionId=870c9653155, topicName=铁代谢)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d84f9850762, createdName=syscxl, createdTime=Thu May 19 10:48:00 CST 2016, time=2016-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=86210, encodeId=340986210a8, content=近年来对一些金属离子的代谢对疾病的影响,也特别引人关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Tue May 17 21:26:00 CST 2016, time=2016-05-17, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1840888, encodeId=0e921840888bf, content=<a href='/topic/show?id=18bf61953d3' target=_blank style='color:#2F92EE;'>#标志物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61953, encryptionId=18bf61953d3, topicName=标志物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ab940, createdName=hukaixun, createdTime=Tue Jun 28 02:48:00 CST 2016, time=2016-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1637329, encodeId=48ad163e32945, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Tue Dec 06 07:48:00 CST 2016, time=2016-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759665, encodeId=0adc1e5966582, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sat Oct 01 06:48:00 CST 2016, time=2016-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901373, encodeId=31cf19013e3e7, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Thu Mar 23 19:48:00 CST 2017, time=2017-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1507030, encodeId=27ea150e030c9, content=<a href='/topic/show?id=870c9653155' target=_blank style='color:#2F92EE;'>#铁代谢#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96531, encryptionId=870c9653155, topicName=铁代谢)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d84f9850762, createdName=syscxl, createdTime=Thu May 19 10:48:00 CST 2016, time=2016-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=86210, encodeId=340986210a8, content=近年来对一些金属离子的代谢对疾病的影响,也特别引人关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Tue May 17 21:26:00 CST 2016, time=2016-05-17, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1840888, encodeId=0e921840888bf, content=<a href='/topic/show?id=18bf61953d3' target=_blank style='color:#2F92EE;'>#标志物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61953, encryptionId=18bf61953d3, topicName=标志物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ab940, createdName=hukaixun, createdTime=Tue Jun 28 02:48:00 CST 2016, time=2016-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1637329, encodeId=48ad163e32945, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Tue Dec 06 07:48:00 CST 2016, time=2016-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759665, encodeId=0adc1e5966582, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sat Oct 01 06:48:00 CST 2016, time=2016-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901373, encodeId=31cf19013e3e7, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Thu Mar 23 19:48:00 CST 2017, time=2017-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1507030, encodeId=27ea150e030c9, content=<a href='/topic/show?id=870c9653155' target=_blank style='color:#2F92EE;'>#铁代谢#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96531, encryptionId=870c9653155, topicName=铁代谢)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d84f9850762, createdName=syscxl, createdTime=Thu May 19 10:48:00 CST 2016, time=2016-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=86210, encodeId=340986210a8, content=近年来对一些金属离子的代谢对疾病的影响,也特别引人关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Tue May 17 21:26:00 CST 2016, time=2016-05-17, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1840888, encodeId=0e921840888bf, content=<a href='/topic/show?id=18bf61953d3' target=_blank style='color:#2F92EE;'>#标志物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61953, encryptionId=18bf61953d3, topicName=标志物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ab940, createdName=hukaixun, createdTime=Tue Jun 28 02:48:00 CST 2016, time=2016-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1637329, encodeId=48ad163e32945, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Tue Dec 06 07:48:00 CST 2016, time=2016-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759665, encodeId=0adc1e5966582, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sat Oct 01 06:48:00 CST 2016, time=2016-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901373, encodeId=31cf19013e3e7, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Thu Mar 23 19:48:00 CST 2017, time=2017-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1507030, encodeId=27ea150e030c9, content=<a href='/topic/show?id=870c9653155' target=_blank style='color:#2F92EE;'>#铁代谢#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96531, encryptionId=870c9653155, topicName=铁代谢)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d84f9850762, createdName=syscxl, createdTime=Thu May 19 10:48:00 CST 2016, time=2016-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=86210, encodeId=340986210a8, content=近年来对一些金属离子的代谢对疾病的影响,也特别引人关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Tue May 17 21:26:00 CST 2016, time=2016-05-17, status=1, ipAttribution=)]
    2016-05-19 syscxl
  6. [GetPortalCommentsPageByObjectIdResponse(id=1840888, encodeId=0e921840888bf, content=<a href='/topic/show?id=18bf61953d3' target=_blank style='color:#2F92EE;'>#标志物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61953, encryptionId=18bf61953d3, topicName=标志物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ab940, createdName=hukaixun, createdTime=Tue Jun 28 02:48:00 CST 2016, time=2016-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1637329, encodeId=48ad163e32945, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Tue Dec 06 07:48:00 CST 2016, time=2016-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759665, encodeId=0adc1e5966582, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sat Oct 01 06:48:00 CST 2016, time=2016-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901373, encodeId=31cf19013e3e7, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Thu Mar 23 19:48:00 CST 2017, time=2017-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1507030, encodeId=27ea150e030c9, content=<a href='/topic/show?id=870c9653155' target=_blank style='color:#2F92EE;'>#铁代谢#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96531, encryptionId=870c9653155, topicName=铁代谢)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d84f9850762, createdName=syscxl, createdTime=Thu May 19 10:48:00 CST 2016, time=2016-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=86210, encodeId=340986210a8, content=近年来对一些金属离子的代谢对疾病的影响,也特别引人关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Tue May 17 21:26:00 CST 2016, time=2016-05-17, status=1, ipAttribution=)]
    2016-05-17 medcardio

    近年来对一些金属离子的代谢对疾病的影响,也特别引人关注

    0

相关资讯

Diabetes Res Clin Pract:我国学者发现2型糖尿病与免疫球蛋白的关联

近期发表在Diabetes Res Clin Pract的研究称,成年人IgA水平的增加、IgG和IgM水平的下降与2型糖尿病的发生率有关。天津医科大学公共卫生学院营养流行病学研究所的Xiaoyan Guo博士和同事对10,691名平均年龄51岁的中国成年人进行了研究。所有参与者接受至少一次的体格检查,包括血清免疫学检查。根据WHO标准识别2型糖尿病患者,使用Logistic模型评估免疫球蛋白与2

BMJ研究新闻:二甲双胍——2型糖尿病治疗的一线药物

来自马里兰州巴尔的摩的约翰霍普金斯大学医学院的一项全面的系统回顾和荟萃分析表明,使用二甲双胍治疗2型糖尿病可改善机体的糖化血红蛋白、体重和心血管疾病死亡率,因此支持二甲双胍作为2型糖尿病治疗的一线药物,该研究结果已在线发表于Annals of Internal Medicine。

J HEPATOL:2型糖尿病患者发生严重肝病的风险更大

最新研究显示,2型糖尿病患者比没有糖尿病的人群发生严重肝病的风险更大。原始出处:H. Wild, Joanne R. Morling, David A. McAllister,et al.Type 2 diabetes and risk of hospital admission or death for chronic liver diseases,Journal of Hepatology,2

常吃点梨吧,不仅可以降压,还可以改善血管功能

你可能知道吃梨具有许多好处,例如可帮助减肥和降低患癌症、高血压、糖尿病和心脏病的风险。现在,一项新的研究表明,每天吃梨还有另一个好处。 美国科罗拉多州立大学的研究人员发现,具有患心血管疾病和2型糖尿病高风险的民众可通过每天吃梨改善他们的血压状况和血管功能。他们进行了一项随机、安慰剂对照交叉临床实验,参与者共有50名,平均年龄为45-65岁,且都表现出代谢综合征(MetS)5项症状中的3项,这表明他

JAMA Cardiol:2型糖尿病患者使用西他列汀不会增加房颤入院的风险(TECOS研究)

以前试验结果表明,二肽基肽酶4抑制剂(DPP4i)的使用可能会增加2型糖尿病(T2DM)患者的心脏衰竭(HF)的风险。在西他列汀对于心血管预后的评价试验(TECOS)中,试验结果表明,对于一级和二级复合动脉粥样硬化性心血管(CV)的结果,DPP4i西他列汀已经被证明其效果不优于安慰剂。该研究的目的是评估HF入院(hHF)使用西他列汀和相关结果的联系。TECOS是一项随机,双盲,安慰剂对照研究,来自

Experimental Psychology:垃圾食品和高脂肪饮食对肾脏的损伤不亚于2型糖尿病

Experimental Psychology:垃圾食品高脂肪饮食对肾脏的损伤不亚于2型糖尿病如果对2型糖尿病管理不当则可引起严重的肾损伤。近日,据发表于Experimental Psychology的一项新的研究表明,摄入过量的垃圾食品或高脂肪饮食也导致同样地肾损伤。该研究结果表明高脂肪饮食或垃圾食品或可升高血糖的水平,其程度与2型糖尿病所致的类似。2型糖尿病是最常见的糖尿病类型,约占糖尿病的9